Anti-OAS3 antibody

• IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OAS3 antibody (AB154270)

Immunohistochemical analysis of paraffin-embedded Human D54MG xenograft tissue, labeling OAS3 with ab154270 at 1/500 dilution.

• WB

Unknown

Western blot - Anti-OAS3 antibody (AB154270)

7.5% SDS PAGE

All lanes:

Western blot - Anti-OAS3 antibody (ab154270) at 1/3000 dilution

All lanes:

A431 whole cell lysate at 30 µg

Predicted band size: 121 kDa

false

• WB

CiteAb

Western blot - Anti-OAS3 antibody (AB154270)

Western Blotting using Anti-OAS3 antibody, ab154270. Publication image from Odon, V. et al., 2019, Nucleic Acids Res, 31276592. Legend direct from paper.

Induction of ZAP, RNAseL and OAS3 on E7 infection. (A) Induction of ZAP (L and S isoforms), RNAseL and OAS3 on infection with E7 over 10 h post-infection with E7 and compositionally altered mutants. (B) Effects of IRF3 pathway inhibition by NPro and of ZAP k/o on RNAseL and OAS3 expression in cells infected with E7 WT.

false

• WB

CiteAb

Western blot - Anti-OAS3 antibody (AB154270)

Western Blotting using Anti-OAS3 antibody, ab154270. Publication image from Odon, V. et al., 2019, Nucleic Acids Res, 31276592. Legend direct from paper.

Expression of ZAP, RNAseL and OAS3 in cell lines; association of ZAP expression with attenuation. Detection of ZAP-L and ZAP-S (A) and RNAseL, and OAS3 (B) by western blot analysis of lysates of different cell lines before and after stimulation with exogenous IFN-β. (C) Association of ZAP-L expression with the attenuation index of mutants of E7 with high CpG or UpA 3′UTR sequences. The black and grey dotted lines show lines of best fit and associated R values. Significance levels were based on one-tailed probabilities using the Spearman non-parametric test.

false